For both liver regeneration and spontaneous HCC development, there is an inclusive requirement for MET expression, and when HGF induces autocrine activation, the tumor displays sensitivity to a small-molecule MET inhibitor. The gene discussed is MET; the disease is hepatocellular carcinoma.